Responses
Regular and young investigator award abstracts
Combination immunotherapies
470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
